Your search returned 8 results.

Results
	1.	Avelumab: clinical trial innovation and collaboration to advance anti-PD-L1 immunotherapy. [electronic resource] by Chin, K Chand, V K Nuyten, D S A Producer: 20180523 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 28 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	From nanotechnology to nanomedicine: applications to cancer research. [electronic resource] by Seigneuric, R Markey, L Nuyten, D S A Dubernet, C Evelo, C T A Finot, E Garrido, C Producer: 20110111 In: Current molecular medicine vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	The impact of inter-observer variation in pathological assessment of node-negative breast cancer on clinical risk assessment and patient selection for adjuvant systemic treatment. [electronic resource] by Bueno-de-Mesquita, J M Nuyten, D S A Wesseling, J van Tinteren, H Linn, S C van de Vijver, M J Producer: 20100224 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	No common denominator for breast cancer lymph node metastasis. [electronic resource] by Weigelt, B Wessels, L F A Bosma, A J Glas, A M Nuyten, D S A He, Y D Dai, H Peterse, J L van't Veer, L J Producer: 20051121 In: British journal of cancer vol. 93 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Robust prognostic value of a knowledge-based proliferation signature across large patient microarray studies spanning different cancer types. [electronic resource] by Starmans, M H W Krishnapuram, B Steck, H Horlings, H Nuyten, D S A van de Vijver, M J Seigneuric, R Buffa, F M Harris, A L Wouters, B G Lambin, P Producer: 20081230 In: British journal of cancer vol. 99 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Phase I dose-escalation study to determine the safety, pharmacokinetics and pharmacodynamics of brivanib alaninate in combination with full-dose cetuximab in patients with advanced gastrointestinal malignancies who have failed prior therapy. [electronic resource] by Garrett, C R Siu, L L El-Khoueiry, A Buter, J Rocha-Lima, C M Marshall, J LoRusso, P Major, P Chemidlin, J Mokliatchouk, O Velasquez, L Hayes, W Feltquate, D Syed, S Ford, S Kollia, G Galbraith, S Nuyten, D S A Producer: 20110922 In: British journal of cancer vol. 105 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	A phase I study to determine the safety, pharmacokinetics and pharmacodynamics of a dual VEGFR and FGFR inhibitor, brivanib, in patients with advanced or metastatic solid tumors. [electronic resource] by Jonker, D J Rosen, L S Sawyer, M B de Braud, F Wilding, G Sweeney, C J Jayson, G C McArthur, G A Rustin, G Goss, G Kantor, J Velasquez, L Syed, S Mokliatchouk, O Feltquate, D M Kollia, G Nuyten, D S A Galbraith, S Producer: 20111128 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 22 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Validation of 70-gene prognosis signature in node-negative breast cancer. [electronic resource] by Bueno-de-Mesquita, J M Linn, S C Keijzer, R Wesseling, J Nuyten, D S A van Krimpen, C Meijers, C de Graaf, P W Bos, M M E M Hart, A A M Rutgers, E J T Peterse, J L Halfwerk, H de Groot, R Pronk, A Floore, A N Glas, A M Van't Veer, L J van de Vijver, M J Producer: 20091216 In: Breast cancer research and treatment vol. 117 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)